Biopharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Monoclonal Antibody, Insulin, Vaccine, Hormone), By Disease, By Drug Type, By Drug Development Type, By Formulation, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Molecule Type
                        1.2.2. Disease
                        1.2.3. Drug Type
                        1.2.4. Drug Development Type
                        1.2.5. Formulation
                        1.2.6. Route of Administration
                        1.2.7. Prescription Type
                        1.2.8. Sales Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Biopharmaceutical Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Pricing Analysis
Chapter 4. Biopharmaceutical Market: Molecule Type Business Analysis
                    4.1. Molecule Type Market Share, 2024 & 2030
                    4.2. Molecule Type Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Molecule Type , 2018 to 2030 (USD Million)
                    4.4. Monoclonal Antibody
                        4.4.1. Monoclonal Antibody Market, 2018 - 2030 (USD Million)
                    4.5. Interferon
                        4.5.1. Interferon Market, 2018 - 2030 (USD Million)
                    4.6. Insulin
                        4.6.1. Insulin Market, 2018 - 2030 (USD Million)
                    4.7. Growth and Coagulation Factor
                        4.7.1. Growth and Coagulation Factor Market, 2018 - 2030 (USD Million)
                    4.8. Erythropoietin
                        4.8.1. Erythropoietin Market, 2018 - 2030 (USD Million)
                    4.9. Vaccine
                        4.9.1. Vaccine Market, 2018 - 2030 (USD Million)
                    4.10. Hormone
                        4.10.1. Hormone Market, 2018 - 2030 (USD Million)
                    4.11. Others
                        4.11.1. Other Type Market, 2018 - 2030 (USD Million)
Chapter 5. Biopharmaceutical Market: Disease Business Analysis
                    5.1. Disease Market Share, 2024 & 2030
                    5.2. Disease Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Disease, 2018 to 2030 (USD Million)
                    5.4. Oncology
                        5.4.1. Oncology Market, 2018 - 2030 (USD Million)
                    5.5. Blood Disorder
                        5.5.1. Blood Disorder Market, 2018 - 2030 (USD Million)
                    5.6. Metabolic Disease
                        5.6.1. Metabolic Disease Market, 2018 - 2030 (USD Million)
                    5.7. Infectious Disease
                        5.7.1. Infectious Disease Market, 2018 - 2030 (USD Million)
                    5.8. Cardiovascular Disease
                        5.8.1. Cardiovascular Disease Market, 2018 - 2030 (USD Million)
                    5.9. Neurological Disease
                        5.9.1. Neurological Disease Market, 2018 - 2030 (USD Million)
                    5.10. Immunology
                        5.10.1. Immunology Market, 2018 - 2030 (USD Million)
                    5.11. Others
                        5.11.1. Other Type Market, 2018 - 2030 (USD Million)
Chapter 6. Biopharmaceutical Market: Drug Type Business Analysis
                    6.1. Drug Type Market Share, 2024 & 2030
                    6.2. Drug Type Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
                    6.4. Proprietary (Branded)
                        6.4.1. Proprietary (Branded) Market, 2018 - 2030 (USD Million)
                        6.4.2. Biosimilars
                            6.4.2.1. Biosimilars Market, 2018 - 2030 (USD Million)
Chapter 7. Biopharmaceutical Market: Drug Development Type Business Analysis
                    7.1. Drug Development Type Market Share, 2024 & 2030
                    7.2. Drug Development Type Segment Dashboard
                    7.3. Market Size & Forecasts and Trend Analysis, by Drug Development Type, 2018 to 2030 (USD Million)
                    7.4. Outsource
                        7.4.1. Outsource Market, 2018 - 2030 (USD Million)
                    7.5. In-house
                        7.5.1. In-house Market, 2018 - 2030 (USD Million)
Chapter 8. Biopharmaceutical Market: Formulation Business Analysis
                    8.1. Formulation Market Share, 2024 & 2030
                    8.2. Formulation Segment Dashboard
                    8.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
                    8.4. Injectables (IV, IM, SC)
                        8.4.1. Injectables (IV, IM, SC) Market, 2018 - 2030 (USD Million)
                    8.5. Inhalation/Nasal Sprays
                        8.5.1. Inhalation/Nasal Sprays Market, 2018 - 2030 (USD Million)
                    8.6. Other Formulations
                        8.6.1. Other Formulations Market, 2018 - 2030 (USD Million)
Chapter 9. Biopharmaceutical Market: Route of Administration Business Analysis
                    9.1. Route of Administration Market Share, 2024 & 2030
                    9.2. Route of Administration Segment Dashboard
                    9.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
                    9.4. Parenteral (IV, IM, SC)
                        9.4.1. Parenteral (IV, IM, SC) Market, 2018 - 2030 (USD Million)
                    9.5. Inhalation/Nasal
                        9.5.1. Inhalation/Nasal Market, 2018 - 2030 (USD Million)
                    9.6. Other Routes
                        9.6.1. Other Routes Market, 2018 - 2030 (USD Million)
Chapter 10. Biopharmaceutical Market: Prescription Type Business Analysis
                    10.1. Prescription Type Market Share, 2024 & 2030
                    10.2. Prescription Type Segment Dashboard
                    10.3. Market Size & Forecasts and Trend Analysis, by Prescription Type, 2018 to 2030 (USD Million)
                    10.4. Prescription Medicines
                        10.4.1. Prescription Medicines Market, 2018 - 2030 (USD Million)
                    10.5. Over-the-counter (OTC) Medicines
                        10.5.1. Over-the-counter (OTC) Medicines Market, 2018 - 2030 (USD Million)
Chapter 11. Biopharmaceutical Market: Sales Channel Business Analysis
                    11.1. Sales Channel Market Share, 2024 & 2030
                    11.2. Sales Channel Segment Dashboard
                    11.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
                    11.4. Retail Pharmacies
                        11.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
                    11.5. Non-retail
                        11.5.1. Non-retail Market, 2018 - 2030 (USD Million)
Chapter 12. Biopharmaceutical Market: Regional Estimates & Trend Analysis
                    12.1. Regional Market Share Analysis, 2024 & 2030
                    12.2. Regional Market Dashboard
                    12.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
                    12.4. North America
                        12.4.1. North America Biopharmaceutical Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        12.4.2. U.S.
                            12.4.2.1. Key Country Dynamics
                            12.4.2.2. Target Disease Prevalence
                            12.4.2.3. Regulatory Framework
                            12.4.2.4. Reimbursement Framework
                            12.4.2.5. U.S. Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.4.3. Canada
                            12.4.3.1. Key Country Dynamics
                            12.4.3.2. Target Disease Prevalence
                            12.4.3.3. Regulatory Framework
                            12.4.3.4. Reimbursement Framework
                            12.4.3.5. U.S. Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.4.4. Mexico
                            12.4.4.1. Key Country Dynamics
                            12.4.4.2. Target Disease Prevalence
                            12.4.4.3. Regulatory Framework
                            12.4.4.4. Reimbursement Framework
                            12.4.4.5. Mexico Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    12.5. Europe
                        12.5.1. Europe Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.2. UK
                            12.5.2.1. Key Country Dynamics
                            12.5.2.2. Target Disease Prevalence
                            12.5.2.3. Regulatory Framework
                            12.5.2.4. Reimbursement Framework
                            12.5.2.5. Uk Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.3. Germany
                            12.5.3.1. Key Country Dynamics
                            12.5.3.2. Target Disease Prevalence
                            12.5.3.3. Regulatory Framework
                            12.5.3.4. Reimbursement Framework
                            12.5.3.5. Germany Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.4. France
                            12.5.4.1. Key Country Dynamics
                            12.5.4.2. Target Disease Prevalence
                            12.5.4.3. Regulatory Framework
                            12.5.4.4. Reimbursement Framework
                            12.5.4.5. France Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.5. Italy
                            12.5.5.1. Key Country Dynamics
                            12.5.5.2. Target Disease Prevalence
                            12.5.5.3. Regulatory Framework
                            12.5.5.4. Reimbursement Framework
                            12.5.5.5. Italy Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.6. Spain
                            12.5.6.1. Key Country Dynamics
                            12.5.6.2. Target Disease Prevalence
                            12.5.6.3. Regulatory Framework
                            12.5.6.4. Reimbursement Framework
                            12.5.6.5. Spain Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.7. Denmark
                            12.5.7.1. Key Country Dynamics
                            12.5.7.2. Target Disease Prevalence
                            12.5.7.3. Regulatory Framework
                            12.5.7.4. Reimbursement Framework
                            12.5.7.5. Denmark Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.8. Sweden
                            12.5.8.1. Key Country Dynamics
                            12.5.8.2. Target Disease Prevalence
                            12.5.8.3. Regulatory Framework
                            12.5.8.4. Reimbursement Framework
                            12.5.8.5. Sweden Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.5.9. Norway
                            12.5.9.1. Key Country Dynamics
                            12.5.9.2. Target Disease Prevalence
                            12.5.9.3. Regulatory Framework
                            12.5.9.4. Reimbursement Framework
                            12.5.9.5. Norway Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    12.6. Asia Pacific
                        12.6.1. Asia Pacific Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.2. Japan
                            12.6.2.1. Key Country Dynamics
                            12.6.2.2. Target Disease Prevalence
                            12.6.2.3. Regulatory Framework
                            12.6.2.4. Reimbursement Framework
                            12.6.2.5. Japan Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.3. China
                            12.6.3.1. Key Country Dynamics
                            12.6.3.2. Target Disease Prevalence
                            12.6.3.3. Regulatory Framework
                            12.6.3.4. Reimbursement Framework
                            12.6.3.5. China Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.4. India
                            12.6.4.1. Key Country Dynamics
                            12.6.4.2. Target Disease Prevalence
                            12.6.4.3. Regulatory Framework
                            12.6.4.4. Reimbursement Framework
                            12.6.4.5. India Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.5. Australia
                            12.6.5.1. Key Country Dynamics
                            12.6.5.2. Target Disease Prevalence
                            12.6.5.3. Regulatory Framework
                            12.6.5.4. Reimbursement Framework
                            12.6.5.5. Australia Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.6. South Korea
                            12.6.6.1. Key Country Dynamics
                            12.6.6.2. Target Disease Prevalence
                            12.6.6.3. Regulatory Framework
                            12.6.6.4. Reimbursement Framework
                            12.6.6.5. South Korea Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.6.7. Thailand
                            12.6.7.1. Key Country Dynamics
                            12.6.7.2. Target Disease Prevalence
                            12.6.7.3. Regulatory Framework
                            12.6.7.4. Reimbursement Framework
                            12.6.7.5. Thailand Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    12.7. Latin America
                        12.7.1. Latin America Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.7.2. Brazil
                            12.7.2.1. Key Country Dynamics
                            12.7.2.2. Target Disease Prevalence
                            12.7.2.3. Regulatory Framework
                            12.7.2.4. Reimbursement Framework
                            12.7.2.5. Japan Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.7.3. Argentina
                            12.7.3.1. Key Country Dynamics
                            12.7.3.2. Target Disease Prevalence
                            12.7.3.3. Regulatory Framework
                            12.7.3.4. Reimbursement Framework
                            12.7.3.5. China Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    12.8. Middle East and Africa
                        12.8.1. Middle East and Africa Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.8.2. South Africa
                            12.8.2.1. Key Country Dynamics
                            12.8.2.2. Target Disease Prevalence
                            12.8.2.3. Regulatory Framework
                            12.8.2.4. Reimbursement Framework
                            12.8.2.5. South Africa Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.8.3. Saudi Arabia
                            12.8.3.1. Key Country Dynamics
                            12.8.3.2. Target Disease Prevalence
                            12.8.3.3. Regulatory Framework
                            12.8.3.4. Reimbursement Framework
                            12.8.3.5. Saudi Arabia Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.8.4. UAE
                            12.8.4.1. Key Country Dynamics
                            12.8.4.2. Target Disease Prevalence
                            12.8.4.3. Regulatory Framework
                            12.8.4.4. Reimbursement Framework
                            12.8.4.5. UAE Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        12.8.5. Kuwait
                            12.8.5.1. Key Country Dynamics
                            12.8.5.2. Target Disease Prevalence
                            12.8.5.3. Regulatory Framework
                            12.8.5.4. Reimbursement Framework
                            12.8.5.5. Kuwait Biopharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 13. Competitive Landscape
                    13.1. Participant Overview
                    13.2. Company Market Position Analysis
                    13.3. Company Categorization
                    13.4. Strategy Mapping
                    13.5. Company Profiles/Listing
                        13.5.1. F. Hoffmann-La Roche Ltd
                            13.5.1.1. Overview
                            13.5.1.2. Financial Performance
                            13.5.1.3. Product Benchmarking
                            13.5.1.4. Strategic Initiatives
                        13.5.2. Novartis AG
                            13.5.2.1. Overview
                            13.5.2.2. Financial Performance
                            13.5.2.3. Product Benchmarking
                            13.5.2.4. Strategic Initiatives
                        13.5.3. AbbVie Inc.
                            13.5.3.1. Overview
                            13.5.3.2. Financial Performance
                            13.5.3.3. Product Benchmarking
                            13.5.3.4. Strategic Initiatives
                        13.5.4. Johnson & Johnson Services, Inc.
                            13.5.4.1. Overview
                            13.5.4.2. Financial Performance
                            13.5.4.3. Product Benchmarking
                            13.5.4.4. Strategic Initiatives
                        13.5.5. Merck & Co., Inc.
                            13.5.5.1. Overview
                            13.5.5.2. Financial Performance
                            13.5.5.3. Product Benchmarking
                            13.5.5.4. Strategic Initiatives
                        13.5.6. Pfizer Inc.
                            13.5.6.1. Overview
                            13.5.6.2. Financial Performance
                            13.5.6.3. Product Benchmarking
                            13.5.6.4. Strategic Initiatives
                        13.5.7. Bristol-Myers Squibb Company
                            13.5.7.1. Overview
                            13.5.7.2. Financial Performance
                            13.5.7.3. Product Benchmarking
                            13.5.7.4. Strategic Initiatives
                        13.5.8. Sanofi
                            13.5.8.1. Overview
                            13.5.8.2. Financial Performance
                            13.5.8.3. Product Benchmarking
                            13.5.8.4. Strategic Initiatives
                        13.5.9. GSK plc.
                            13.5.9.1. Overview
                            13.5.9.2. Financial Performance
                            13.5.9.3. Product Benchmarking
                            13.5.9.4. Strategic Initiatives
                        13.5.10. AstraZeneca
                            13.5.10.1. Overview
                            13.5.10.2. Financial Performance
                            13.5.10.3. Product Benchmarking
                            13.5.10.4. Strategic Initiatives
                        13.5.11. Takeda Pharmaceutical Company Limited
                            13.5.11.1. Overview
                            13.5.11.2. Financial Performance
                            13.5.11.3. Product Benchmarking
                            13.5.11.4. Strategic Initiatives
                        13.5.12. Biogen
                            13.5.12.1. Overview
                            13.5.12.2. Financial Performance
                            13.5.12.3. Product Benchmarking
                            13.5.12.4. Strategic Initiatives
                        13.5.13. Eli Lilly and Company
                            13.5.13.1. Overview
                            13.5.13.2. Financial Performance
                            13.5.13.3. Product Benchmarking
                            13.5.13.4. Strategic Initiatives
                        13.5.14. Novo Nordisk A/S
                            13.5.14.1. Overview
                            13.5.14.2. Financial Performance
                            13.5.14.3. Product Benchmarking
                            13.5.14.4. Strategic Initiatives
                        13.5.15. Amgen Inc.
                            13.5.15.1. Overview
                            13.5.15.2. Financial Performance
                            13.5.15.3. Product Benchmarking
                            13.5.15.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Biopharmaceutical Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 5 Global Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 6 Global Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 7 Global Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 8 Global Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 9 Global Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 10 Global Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 11 Global Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 12 North America Biopharmaceutical Market, by Country, 2018 - 2030 (USD Million)
Table 13 North America Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 14 North America Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 15 North America Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 16 North America Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 17 North America Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 18 North America Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 19 North America Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 20 North America Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 21 US Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 22 US Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 23 US Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 24 US Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 25 US Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 26 US Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 27 US Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 28 US Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 29 Canada Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 30 Canada Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 31 Canada Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 32 Canada Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 33 Canada Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 34 Canada Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 35 Canada Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 36 Canada Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 37 Mexico Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 38 Mexico Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 39 Mexico Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 40 Mexico Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 41 Mexico Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 42 Mexico Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 43 Mexico Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 44 Mexico Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 45 Europe Biopharmaceutical Market, by Country, 2018 - 2030 (USD Million)
Table 46 Europe Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 47 Europe Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 48 Europe Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 49 Europe Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 50 Europe Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 51 Europe Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 52 Europe Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 53 Europe Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 54 UK Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 55 UK Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 56 UK Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 57 UK Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 58 UK Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 59 UK Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 60 UK Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 61 UK Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 62 Germany Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 63 Germany Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 64 Germany Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 65 Germany Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 66 Germany Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 67 Germany Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 68 Germany Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 69 Germany Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 70 France Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 71 France Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 72 France Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 73 France Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 74 France Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 75 France Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 76 France Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 77 France Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 78 Italy Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 79 Italy Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 80 Italy Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 81 Italy Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 82 Italy Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 83 Italy Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 84 Italy Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 85 Italy Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 86 Spain Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 87 Spain Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 88 Spain Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 89 Spain Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 90 Spain Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 91 Spain Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 92 Spain Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 93 Spain Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 94 Norway Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 95 Norway Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 96 Norway Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 97 Norway Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 98 Norway Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 99 Norway Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 100 Norway Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 101 Norway Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 102 Denmark Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 103 Denmark Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 104 Denmark Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 105 Denmark Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 106 Denmark Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 107 Denmark Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 108 Denmark Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 109 Denmark Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 110 Sweden Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 111 Sweden Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 112 Sweden Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 113 Sweden Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 114 Sweden Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 115 Sweden Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 116 Sweden Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 117 Sweden Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 118 Asia Pacific Biopharmaceutical Market, by Country, 2018 - 2030 (USD Million)
Table 119 Asia Pacific Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 120 Asia Pacific Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 121 Asia Pacific Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 122 Asia Pacific Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 123 Asia Pacific Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 124 Asia Pacific Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 125 Asia Pacific Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 126 Asia Pacific Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 127 Japan Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 128 Japan Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 129 Japan Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 130 Japan Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 131 Japan Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 132 Japan Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 133 Japan Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 134 Japan Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 135 China Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 136 China Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 137 China Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 138 China Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 139 China Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 140 China Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 141 China Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 142 China Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 143 India Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 144 India Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 145 India Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 146 India Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 147 India Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 148 India Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 149 India Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 150 India Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 151 Australia Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 152 Australia Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 153 Australia Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 154 Australia Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 155 Australia Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 156 Australia Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 157 Australia Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 158 Australia Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 159 South Korea Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 160 South Korea Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 161 South Korea Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 162 South Korea Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 163 South Korea Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 164 South Korea Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 165 South Korea Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 166 South Korea Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 167 Thailand Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 168 Thailand Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 169 Thailand Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 170 Thailand Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 171 Thailand Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 172 Thailand Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 173 Thailand Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 174 Thailand Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 175 Latin America Biopharmaceutical Market, by Country, 2018 - 2030 (USD Million)
Table 176 Latin America Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 177 Latin America Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 178 Latin America Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 179 Latin America Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 180 Latin America Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 181 Latin America Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 182 Latin America Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 183 Latin America Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 184 Brazil Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 185 Brazil Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 186 Brazil Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 187 Brazil Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 188 Brazil Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 189 Brazil Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 190 Brazil Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 191 Brazil Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 192 Argentina Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 193 Argentina Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 194 Argentina Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 195 Argentina Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 196 Argentina Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 197 Argentina Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 198 Argentina Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 199 Argentina Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 200 Middle East & Africa Biopharmaceutical Market, by Country, 2018 - 2030 (USD Million)
Table 201 Middle East & Africa Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 202 Middle East & Africa Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 203 Middle East & Africa Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 204 Middle East & Africa Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 205 Middle East & Africa Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 206 Middle East & Africa Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 207 Middle East & Africa Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 208 Middle East & Africa Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 209 South Africa Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 210 South Africa Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 211 South Africa Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 212 South Africa Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 213 South Africa Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 214 South Africa Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 215 South Africa Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 216 South Africa Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 217 Saudi Arabia Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 218 Saudi Arabia Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 219 Saudi Arabia Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 220 Saudi Arabia Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 221 Saudi Arabia Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 222 Saudi Arabia Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 223 Saudi Arabia Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 224 Saudi Arabia Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 225 UAE Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 226 UAE Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 227 UAE Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 228 UAE Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 229 UAE Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 230 UAE Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 231 UAE Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 232 UAE Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 233 Kuwait Biopharmaceutical Market, by Molecule Type, 2018 - 2030 (USD Million)
Table 234 Kuwait Biopharmaceutical Market, by Disease, 2018 - 2030 (USD Million)
Table 235 Kuwait Biopharmaceutical Market, by Drug Type, 2018 - 2030 (USD Million)
Table 236 Kuwait Biopharmaceutical Market, by Drug Development Type, 2018 - 2030 (USD Million)
Table 237 Kuwait Biopharmaceutical Market, by Formulation, 2018 - 2030 (USD Million)
Table 238 Kuwait Biopharmaceutical Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 239 Kuwait Biopharmaceutical Market, by Prescription Type, 2018 - 2030 (USD Million)
Table 240 Kuwait Biopharmaceutical Market, by Sales Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Biopharmaceutical market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Segment snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market value, 2024 (USD billion)
Fig. 16 Market dynamics
Fig. 17 Global large pharma R&D spending in 2018 - 2023 (USD Billion)
Fig. 18 Porter’s five forces analysis
Fig. 19 PESTLE analysis
Fig. 20 Biopharmaceutical market: Molecule type outlook and key takeaways
Fig. 21 Biopharmaceutical market: Molecule type movement analysis
Fig. 22 Monoclonal antibody market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Interferon market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Insulin market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Growth and coagulation factor market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Erythropoietin market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Hormone market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Biopharmaceutical market: Disease outlook and key takeaways
Fig. 31 Biopharmaceutical market: Disease movement analysis
Fig. 32 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Blood disorder market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Metabolic disease market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Infectious disease market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Neurological disease market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 Immunology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 Biopharmaceutical market: Drug Type outlook and key takeaways
Fig. 41 Biopharmaceutical market: Drug type movement analysis
Fig. 42 Proprietary (Branded) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Biosimilars market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Biopharmaceutical market: Drug development type outlook and key takeaways
Fig. 45 Biopharmaceutical market: Drug development type movement analysis
Fig. 46 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Biopharmaceutical market: Formulation outlook and key takeaways
Fig. 49 Biopharmaceutical market: Formulation movement analysis
Fig. 50 Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Inhalation/nasal sprays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Other formulations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Biopharmaceutical market: Prescription outlook and key takeaways
Fig. 54 Biopharmaceutical market: Prescription movement analysis
Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 OTC market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 Biopharmaceuticals market: Route of administration outlook and key takeaways
Fig. 58 Biopharmaceuticals market: Route of administration movement analysis
Fig. 59 Parenteral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Inhalations/Nasal market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Other routes of administration market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 Biopharmaceuticals market Sales channel market outlook and key takeaways
Fig. 63 Biopharmaceuticals market Sales channel market movement analysis
Fig. 64 Retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 65 Non-retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Biopharmaceutical market revenue, by region, 2024 & 2030 (USD Billion)
Fig. 67 Regional marketplace: Key takeaways
Fig. 68 North America biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 69 Key country dynamics
Fig. 70 U.S. biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 71 Cancer incidence, 2022-2045
Fig. 72 U.S. healthcare system: money flow
Fig. 73 Key country dynamics
Fig. 74 Canada biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 75 Cancer incidence, 2022-2045
Fig. 76 Key country dynamics
Fig. 77 Mexico biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Cancer incidence, 2022-2045
Fig. 79 Regulatory framework
Fig. 80 Europe biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 81 Obesity and diabetes in European nations
Fig. 82 Causes of mortality in Europe
Fig. 83 Key country dynamics
Fig. 84 UK biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 85 Cancer incidence, 2022-2045
Fig. 86 Key country dynamics
Fig. 87 Germany biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 88 Cancer incidence, 2022-2045
Fig. 89 R&D spending
Fig. 90 Exclusivity formula
Fig. 91 Germany insurance coverage
Fig. 92 Key country dynamics
Fig. 93 France biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 94 Cancer incidence, 2022-2045
Fig. 95 Key country dynamics
Fig. 96 Italy biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 97 Cancer incidence, 2022-2045
Fig. 98 Key country dynamics
Fig. 99 Spain biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 100 Cancer incidence, 2022-2045
Fig. 101 Key country dynamics
Fig. 102 Denmark biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 103 Cancer Incidence, 2022-2045
Fig. 104 Key country dynamics
Fig. 105 Sweden biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 106 Cancer incidence 2022-2045
Fig. 107 Key country dynamics
Fig. 108 Norway biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 109 Cancer incidence, 2022-2045
Fig. 110 Rest of Europe biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 111 Asia Pacific biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 112 Key country dynamics
Fig. 113 Japan biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 114 Cancer incidence, 2022-2045
Fig. 115 Japan pharmaceutical registration
Fig. 116 Key country dynamics
Fig. 117 China biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 118 Cancer incidence, 2022-2045
Fig. 119 Regulatory details: China
Fig. 120 Key country dynamics
Fig. 121 India biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 122 Cancer incidence, 2018 - 2030
Fig. 123 Key country dynamics
Fig. 124 Australia biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 125 Cancer incidence, 2018 - 2030
Fig. 126 Key country dynamics
Fig. 127 Thailand biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 128 Cancer incidence, 2018 - 2030
Fig. 129 Key country dynamics
Fig. 130 South Korea biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 131 Cancer incidence, 2018 - 2030
Fig. 132 Rest of Asia Pacific biopharmaceutical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 133 Latin America biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 134 Key country dynamics
Fig. 135 Brazil biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 136 Cancer incidence, 2018 - 2030
Fig. 137 Key country dynamics
Fig. 138 Argentina biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 139 Cancer incidence, 2018 - 2030
Fig. 140 Rest of Latin America biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 141 MEA biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 142 Key country dynamics
Fig. 143 South Africa biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 144 Cancer incidence, 2018 - 2030
Fig. 145 Key country dynamics
Fig. 146 Saudi Arabia biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 147 Cancer incidence, 2018 - 2030
Fig. 148 Key country dynamics
Fig. 149 UAE biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 150 Cancer incidence, 2018 - 2030
Fig. 151 UAE import and export details
Fig. 152 Key country dynamics
Fig. 153 Kuwait biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 154 Cancer incidence, 2018 - 2030
Fig. 155 Kuwait imports and export details
Fig. 156 Rest of MEA biopharmaceutical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 157 Company/competition categorization
Fig. 160 Strategy mapping